Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease
In the last five years, the medical community was astonishingly surprised by the sequential large outcome trials that displayed the renal effects of sodium glucose co-transporter inhibitors (SGLT2Is) in type 2 diabetes mellitus (T2DM) patients with or without chronic kidney disease (CKD). This favor...
Main Authors: | Usama Abdel Azim Sharaf El Din, Mona Mansour Salem, Dina Ossama Abdulazim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Nefrología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2013251422000864 |
Similar Items
-
Características clínicas de los pacientes diabéticos que acuden por primera vez a una consulta nefrológica en hospitales públicos de Lima
by: Percy Herrera Añazco, et al.
Published: (2014-01-01) -
Síndrome de Berardinelli-Seip en diálisis peritoneal
by: José Joaquín Bande-Fernández, et al.
Published: (2015-09-01) -
Educational intervention on chronic renal failure in patients with type-2 diabetes mellitus
by: Onelis Góngora Gómez, et al.
Published: (2019-04-01) -
Educational intervention on chronic renal failure in patients with type-2 diabetes mellitus
by: Onelis Góngora Gómez, et al.
Published: (2019-04-01) -
Aproximación al riesgo de progresión de la enfermedad renal crónica. Experiencia en Botsuana
by: Rafael Enrique Cruz Abascal, et al.
Published: (2018-07-01)